ProHealth health Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Missing protein explains link between obesity, diabetes

Fish oil use associated with brain volume preservation

The Brain Boosting and Fatigue Fighting B-12

Genetic basis for distinct type of autism uncovered

Unsuspected aspect of immune regulation revealed: Role of B cells

IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders

Explaining 'Healthy' Obesity

Sinus Congestion and Sinusitis, Healing Naturally

Ginger's Many Evidence-Based Health Benefits Revealed

Omega 3 Fatty Acids Lessen Severity of Osteoarthritis in Mice

 
Print Page
Email Article

New Study Finds High Prevalence of Chronic Fatigue Syndrome

  [ 112 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 10, 2004


NCID Focus Volume 13 Number 1 Winter 2004 Focus on Viral and Rickettsial Diseases Population-based estimates of the occurrence of chronic fatigue syndrome (CFS) in Wichita, Kan., suggest that the disorder is a major public health problem, particularly among women, according to a published report by Division of Viral and Rickettsial Diseases (DVRD) scientists and their colleagues at private or medical institutions. (Arch Intern Med 2003; 163:1530-6) “When extrapolated to the US population, our estimates indicate that as many as 800,000 adults may have CFS. Fewer than 20% of these individuals will have been diagnosed with CFS and received medical attention for their fatiguing illness,” said William Reeves, chief, Viral Exanthems and Herpesvirus Branch and senior author of the report. Other CDC authors include Michele Reyes, Rosane Nisenbaum, Elizabeth Unger, and the late John Stewart. CFS is a debilitating illness for which there is no known cause or cure. Determining how many people have CFS has been difficult because of researchers’ inconsistent use of case-defining criteria and the lack of reliable laboratory tests for diagnosing the illness. To estimate baseline prevalence and 1-year incidence of CFS, Dr. Reeves and colleagues conducted a 4-year study in Wichita, Kansas, which has a population with demographic features (e.g., age, sex, race, ethnicity, income) similar to those of the US general population. The team used screening and detailed telephone interviews to identify persons 18 years or older with CFS-like illness and performed clinical examinations to further classify subjects with CFS on the basis of a standardized case definition. The overall prevalence of CFS was 235 per 100,000 persons. The illness was more than four times more common among women (373 per 100,000) than among men (83 per 100,000), and it was most common among white women 50 to 59 years of age (863 per 100,000). On average, the illness lasted about 7 years. Among those with CFS, only 16 percent had received a diagnosis and medical treatment for their illness. The 1-year CFS incidence was 180 per 100,000 persons. “These estimates are critical for helping public health officials, health maintenance organizations, and other insurance providers better understand the extent of CFS,” said Reeves. “They are also important in helping practicing physicians put CFS in a realistic context when examining and caring for patients,” he said. Dr. Reeves added that other studies based on data and blood samples collected from the Wichita study population are under way to evaluate the natural history of CFS and to identify potential molecular markers for use in diagnosing this illness. Additional information about CFS is available at www.cdc.gov/ncidod/diseases/cfs/index.htm. Source: CFIDS Association of America, online at www.cfids.org.



Discuss This Article Post a Comment 




[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Featured Products

FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Protect Against Sun-Induced Skin Aging From The Inside Out Protect Against Sun-Induced Skin Aging From The Inside Out
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
Live Longer: Groundbreaking Research on Omega-3s Live Longer: Groundbreaking Research on Omega-3s
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing